
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Dysplastic nevus differential diagnosis
Introduction

Overview
Overview
Dysplastic nevus should be differentiated from common moles and melanoma.
Dysplastic nevus differential diagnosis
Dysplastic nevus differential diagnosis
Dysplastic should be differentiated from:
- Common moles
- Melanoma
Biopsy is the only way to differentiate above mentioned conditions from dysplastic nevus.
| Disease or Condition | Differentiating Signs and Symptoms | Differentiating Tests |
| Microcystic adnexal carcinoma | AKA sclerosing sweat duct carcinoma; simulate morpheaform variants of BCC; higher recurrence rate than BCC | Histopathology: there are more ductal structures lined by a cuticle of keratin, which are not prevalent in BCCs; it will occasionally be positive with cytokeratin 7 and CEA (usually negative in BCCs)[1] |
| Trichoepithelioma/trichoblastoma | There is a formation of papillary-mesenchymal bodies (follicular units that simulate bulb of the hair follicle); a characteristic stroma-stroma split; a lower apoptotic and mitotic rate than seen in BCC[2] | Histopathology: the characteristic stroma-epithelium split and increase in apoptotic bodies and mitotic figures is not seen; Immunohistochemical: a characteristic perinuclear dot-like pattern and high molecular weight cytokeratin cocktail |
| Merkel cell carcinoma | This is a highly malignant neoplasm derived from cutaneous neuroendocrine cells[3] | Histopathology: opaque nuclei, no nucleoli, and increased nuclear/cytoplasmic ratio, peripheral palisading might be present |
| Squamous cell carcinoma (SCC) | It may impossible to distinguish between BCC and SCC[4] | Histopathology: larger cells with prominent nucleoli, foci of keratinization and formation of squamous whorls where the neoplastic cells tightly wrap around each other |
Oral melanoma must be differentiated from other mouth lesions such as oral candidiasis and aphthous ulcer
| Disease | Presentation | Risk Factors | Diagnosis | Affected Organ Systems | Important features | Picture |
|---|---|---|---|---|---|---|
| Diseases predominantly affecting the oral cavity | ||||||
| Oral Candidiasis |
|
|
|
Localized candidiasis
Invasive candidasis |
|
![]() |
| Herpes simplex oral lesions |
|
|
|
|
![]() | |
| Aphthous ulcers |
|
|
|
|
|
![]() |
| Squamous cell carcinoma |
|
|
![]() | |||
| Leukoplakia |
|
|
|
|
![]() | |
| Melanoma |
|
|
|
|
![]() | |
| Fordyce spots |
|
|
|
|
![]() | |
| Burning mouth syndrome |
|
|
||||
| Torus palatinus |
|
![]() | ||||
| Diseases involving oral cavity and other organ systems | ||||||
| Behcet’s disease |
|
|
|
![]() | ||
| Crohn’s disease |
|
|
|
|||
| Agranulocytosis |
|
|
||||
| Syphilis[7] |
|
|
|
![]() | ||
| Coxsackie virus |
|
|
| |||
| Chicken pox |
|
|
|
|
![]() | |
| Measles |
|
|
|
![]() | ||
| Subtype | Frequency | Clinical Features |
| Common Subtypes | ||
| Superficial spreading melanoma | 70% |
|
| Nodular melanoma | 15-25% |
|
| Acral lentiginous melanoma | 5% |
|
| Lentigo maligna melanoma | 1-5% |
|
| Non-cutaneous melanoma | 5% | |
| Less Common Subtypes | ||
| Desmoplastic/Spindle cell melanoma | Rare |
|
| Nevoid melanoma | Rare |
|
| Spitzoid melanocytic neoplasm | Rare |
|
| Angiotropic melanoma | Rare | |
| Blue nevus-like melanoma | Rare |
|
| Composite melanoma | Rare |
|
References
References
- β Smeets NW, Stavast-Kooy AJ, Krekels GA, Daemen MJ, Neumann HA (2003). “Adjuvant cytokeratin staining in Mohs micrographic surgery for basal cell carcinoma”. Dermatol Surg. 29 (4): 375β7. PMIDΒ 12656816.
- β Ackerman AB, Gottlieb GJ (2005). “Fibroepithelial tumor of pinkus is trichoblastic (Basal-cell) carcinoma”. Am J Dermatopathol. 27 (2): 155β9. PMIDΒ 15798443.
- β Massari LP, Kastelan M, Gruber F (2007). “Epidermal malignant tumors: pathogenesis, influence of UV light and apoptosis”. Coll Antropol. 31 Suppl 1: 83β5. PMIDΒ 17469758.
- β Raasch BA, Buettner PG, Garbe C (2006). “Basal cell carcinoma: histological classification and body-site distribution”. Br J Dermatol. 155 (2): 401β7. doi:10.1111/j.1365-2133.2006.07234.x. PMIDΒ 16882181.
- β Ann M. Gillenwater, Nadarajah Vigneswaran, Hanadi Fatani, Pierre Saintigny & Adel K. El-Naggar (2013). “Proliferative verrucous leukoplakia (PVL): a review of an elusive pathologic entity!”. Advances in anatomic pathology. 20 (6): 416β423. doi:10.1097/PAP.0b013e3182a92df1. PMIDΒ 24113312. Unknown parameter
|month=ignored (help) - β AndrΓ¨s E, Zimmer J, Affenberger S, Federici L, Alt M, Maloisel F. (2006). “Idiosyncratic drug-induced agranulocytosis: Update of an old disorder”. Eur J Intern Med. 17 (8): 529β35. Text “pmid 17142169” ignored (help)
- β title=”By Internet Archive Book Images [No restrictions], via Wikimedia Commons” href=”https://commons.wikimedia.org/wiki/File:A_manual_of_syphilis_and_the_venereal_diseases%2C_(1900)_(14595882378).jpg“
- β Feikin DR, Lezotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman RE (2000). “Individual and community risks of measles and pertussis associated with personal exemptions to immunization”. JAMA. 284 (24): 3145β50. PMIDΒ 11135778.
- β Ratnam S, West R, Gadag V, Williams B, Oates E (1996). “Immunity against measles in school-aged children: implications for measles revaccination strategies”. Can J Public Health. 87 (6): 407β10. PMIDΒ 9009400.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]













